The all-new MICRON® 5 platform delivers advanced performance, repeatability, and imaging workflow efficiency Bend, OR, USA, April 21, 2023 – Phoenix-Micron, Inc. today announced the launch of the all-new Phoenix MICRON® 5 imaging system, the latest breakthrough in small animal ophthalmic imaging technology. With over 450 published studies utilizing MICRON imaging systems, the MICRON platform
21.04
2023
Phoenix-Micron, Inc. Announces New, Comprehensive Imaging Software and Redesigned Lens Technology for the Phoenix MICRON® Imaging Platform
Two new innovations, MICRON Software Suite and MICRON LT2 lens technology, streamline the ophthalmic imaging workflow and deliver new data management capabilities. Bend, OR, USA, April 21, 2023– Phoenix-Micron, Inc., a leader in ophthalmic imaging technology, today announced the release of the new MICRON® Software Suite and the MICRON LT2 lens technology. The new
08.03
2023
Researchers at the University of Copenhagen demonstrate for the first time that diet induced obesity (DIO) leads to raised intracranial pressure (ICP) and subsequent clinically relevant symptom development.
In the paper “The impact of obesity‑related raised intracranial pressure in rodents” published in Scientific Reports journal, Westgate and collaborators used the Phoenix MICRON® image-guided OCT system, along with the Phoenix MICRON® Insight software, in the measurement of the retinal anatomical changes caused by intracranial hypertension in obese rats. The Problem: Intracranial pressure (ICP) measures the
29.11
2021
Phoenix MICRON Spins out of Phoenix Technology Group to Better Serve Eye and Eye-Brain Researchers Globally
Bend, OR, USA, November 29, 2021 — The newly formed company, Phoenix-Micron, Inc., announced today it has completed the spin-out of the Phoenix MICRON® imaging platform from Phoenix Technology Group. This move is designed to increase focus and innovation in products designed to serve the eye and eye-brain research community. The new company, Phoenix-Micron, Inc.
19.10
2021
Cataracts caused by lens protein knockout imaged using the Phoenix MICRON® IV Slit Lamp
In their article, “CRYβA3/A1-Crystallin Knockout Develops Nuclear Cataract and Causes Impaired Lysosomal Cargo Clearance and Calpain Activation,” Hegde et al use the Phoenix MICRON® IV Slit Lamp to examine the effect of knocking out a lens structural protein. α, β and γ crystallins are lens structural proteins that are needed for transparency and refractive power
30.08
2021
Creative use of the Phoenix MICRON® system to study corneal wound healing
Hampel et al use the Phoenix MICRON® III imaging platform in an unusual manner in their paper “Relaxin 2 is functional at the ocular surface and promotes corneal wound healing by visualizing enucleated corneas.” The Phoenix MICRON® is designed to take crisp images and videos of the rodent retina, but this article demonstrates the other